About
Contact & Profiles
A5034711099
Research Areas
- Lymphoma Diagnosis and Treatment
- Medical Imaging Techniques and Applications
- Chronic Lymphocytic Leukemia Research
- Lung Cancer Treatments and Mutations
- Radiopharmaceutical Chemistry and Applications
- Radiomics and Machine Learning in Medical Imaging
- Management of metastatic bone disease
- Pelvic and Acetabular Injuries
- Radiation Dose and Imaging
- CNS Lymphoma Diagnosis and Treatment
- Viral-associated cancers and disorders
University of Central Florida
2019-2020
Florida College
2019-2020
10.1016/j.prro.2020.01.009
article
EN
Practical Radiation Oncology
2020-01-28
Classical Hodgkin lymphoma (HL) patients achieve excellent outcomes; therefore, treatment de-escalation strategies to spare toxicity have been prioritized. In a large randomized trial of early stage HL patients, omission chemotherapeutic agents including bleomycin from the standard ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) regimen was not found be non-inferior; however effect partial is unknown. We investigated on outcome for 150 patients. At eight years, freedom relapse 99%...
10.1002/jha2.1
article
EN
cc-by
eJHaem
2020-02-07
10.1016/j.clml.2020.02.008
article
EN
Clinical Lymphoma Myeloma & Leukemia
2020-02-20
10.1016/j.ijrobp.2019.06.1457
article
EN
International Journal of Radiation Oncology*Biology*Physics
2019-09-01
10.1016/j.ijrobp.2019.06.1458
article
EN
International Journal of Radiation Oncology*Biology*Physics
2019-09-01
Coming Soon ...